Department of biomolecular sciences

Proteins mediate nearly all of the essential molecular processes of life. To perform their function, they need to fold into unique structures. At any given moment, thousands of proteins are produced and need to fold in the cell. But folding is an incredibly complex process that very often fails. To deal with this challenge, the cell is equipped with an array of chaperones and proteases, performing quality control functions to safeguard the cell. Failure of these processes underlies numerous devastating diseases. We investigate how these events unfold for membrane proteins, which are proteins that reside at the membrane and make up a quarter of the proteome in every living organism.

Mitochondria are pivotal to the function of eukaryotic cells- WHY? It’s becoming clear that one of their most fundamental and vital roles involves the biosynthesis of iron-sulfur (Fe-S) clusters. These ancient cofactors are crucial for proteins engaged in DNA replication, translation, metabolism, and cellular respiration and more. Given these critical functions, it is not surprising that disruptions in Fe-S cluster synthesis are associated with various human diseases, including the most prevalent mitochondrial disorder (Friedreich’s ataxia). Despite its importance, much remains unknown about this pathway, particularly how it is regulated within the cell. Our lab utilizes cutting-edge genetic, cell biology, and biochemical techniques to unravel this vital pathway and integrate it within the broader context of human cellular function.

We are studying regulation of transcription and translation in health and disease. Specifically we elucidate how the transcription and translation processes control the cellular response to enviromental stimuli, we investigate the connections between the transcription and translation processes and we develop pharmacological tools to manipulate these processes.

We focus on studying the mechanisms that promote chromosome instability, a major driver of cancer initiation, metastasis, and drug resistance. Our group aims to understand the plasticity of the cancer genome and how it contributes to disease progression. To do so, we apply chromosome manipulation approaches in cells, to study how single genomic perturbations affect population trajectories. Our goal is to identify vulnerabilities in mechanisms driving chromosome evolution, in order to design next-generation therapies with reduced resistance in patients.

We are interested in how protein function is encoded in the structures of protein binders, enzymes, and antibodies. To test our understanding we computationally design new protein functions not seen in Nature and experimentally characterize these designs. Iterations of design and experimental characterization enable us to understand new features of how protein function is specified in Nature.

For tumors to expand, metastasize, and evade immune surveillance, genetically transformed cancer cells must recruit non-malignant cells, including macrophages, fibroblasts and endothelial cells. These cells, collectively termed the tumor microenvironment, are reprogrammed to support the tumor at the expense of its host. Our group aims to elucidate the mechanisms by which tumors reprogram their local environments. Our goal is to provide a deeper understanding of how tumors develop into systemic malignancies, predict which tumors are more likely to do so, and design therapeutic strategies to overcome these malignancies by targeting genetically stable elements in the tumor microenvironment.

With malaria continuing to be a major global disease, advances toward understanding the basic biology of P. falciparum remain essential. Our studies focus on different aspects of the cellular biology of the malaria parasite. In particular, we aim to explore cell-cell communication pathways between the parasites themselves and their human host.

We are interested in transport processes and in photosynthesis. Within the realm of photosynthesis we are mainly concerned with dynamic processes that accompany the life cycle of the thylakoid network, including its response to different stresses and its formation and dismantling. Regarding nucleo-cytoplasmic transport, we are particularly interested in its selectivity, the behavior of the ensemble of transporting molecules as it relates to the transport of a single molecule and in applications to gene therapy. In both fields of study, we combine different approaches and methodologies including ensemble and single-molecule biophysical methods, biochemical and molecular biology techniques, statistical mechanical modeling and state-of-the-art electron microscopy.

We aim to discover the mechanisms that control and coordinate the activity of molecular machines involved in the protein degradation pathway. To do so we apply novel native mass spectrometry approaches, in conjunction with fluorescence microscopy, biochemical and cell biology methods - generating an integrative mode of analysis combining in vitro and in vivo findings.

We focus on studying the mechanisms that promote chromosome instability, a major driver of cancer initiation, metastasis, and drug resistance. Our group aims to understand the plasticity of the cancer genome and how it contributes to disease progression. To do so, we apply chromosome manipulation approaches in cells, to study how single genomic perturbations affect population trajectories. Our goal is to identify vulnerabilities in mechanisms driving chromosome evolution, in order to design next-generation therapies with reduced resistance in patients.

For tumors to expand, metastasize, and evade immune surveillance, genetically transformed cancer cells must recruit non-malignant cells, including macrophages, fibroblasts and endothelial cells. These cells, collectively termed the tumor microenvironment, are reprogrammed to support the tumor at the expense of its host. Our group aims to elucidate the mechanisms by which tumors reprogram their local environments. Our goal is to provide a deeper understanding of how tumors develop into systemic malignancies, predict which tumors are more likely to do so, and design therapeutic strategies to overcome these malignancies by targeting genetically stable elements in the tumor microenvironment.

We are investigating the mechanisms that govern the wiring of the nervous system during development, which includes axonal guidance, pruning and the role of local protein synthesis.

We are investigating long distance signaling mechanisms in neurons and other large eukaryotic cells, primarily an importins/molecular motor-based mechanism that integrates cytoplasmic and nuclear signaling. Currently our main focus is on the roles of this and related mechanisms in neuronal responses to injury and in cellular length sensing.

We are studying regulation of transcription and translation in health and disease. Specifically we elucidate how the transcription and translation processes control the cellular response to enviromental stimuli, we investigate the connections between the transcription and translation processes and we develop pharmacological tools to manipulate these processes.

We are interested in how protein function is encoded in the structures of protein binders, enzymes, and antibodies. To test our understanding we computationally design new protein functions not seen in Nature and experimentally characterize these designs. Iterations of design and experimental characterization enable us to understand new features of how protein function is specified in Nature.

Our main research interest is to explore the interplay between the cellular metabolic state and circadian clocks and further identify the underlying molecular mechanisms.